Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Palo Alto, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Eiger BioPharmaceuticals, Inc. has filed 694 SEC EDGAR filings since 05 Oct 2004

SEC filing history

Showing 376-400 of 687 matching filings.

Per page
25
Current page
16
4

FORM 4 SUBMISSION

Filing date
18 Sep 2017
Reporting date
15 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
18 Sep 2017
Reporting date
15 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

FORM 8-K

Filing date
18 Sep 2017
Reporting date
14 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Sep 2017
Reporting date
01 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

8-K

Filing date
01 Sep 2017
Reporting date
31 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87931

SC 13G

Filing date
22 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-219936

S-8

Filing date
11 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36183

10-Q Q2'2017

Filing date
11 Aug 2017
Reporting date
30 Jun 2017
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
20 Jun 2017
Reporting date
14 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

FORM 8-K

Filing date
14 Jun 2017
Reporting date
13 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

FORM 8-K

Filing date
12 May 2017
Reporting date
12 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36183

DEFINITIVE PROXY STATEMENT

Filing date
28 Apr 2017
Reporting date
13 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Apr 2017
Reporting date
12 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Apr 2017
Reporting date
12 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Apr 2017
Reporting date
12 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Apr 2017
Reporting date
12 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Apr 2017
Reporting date
12 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

FORM 8-K

Filing date
23 Mar 2017
Reporting date
23 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Mar 2017
Reporting date
09 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Mar 2017
Reporting date
09 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Mar 2017
Reporting date
09 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Mar 2017
Reporting date
09 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Mar 2017
Reporting date
09 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .